• Home
  • Search Results

Search Results

Adult (35-64)
2283 studies match your search

A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer

The goal of this research study is to test a new study treatment for a specific type of stomach cancer. It is focused on people whose tumors are CLDN18.2 positive, PD-L1 positive, and HER2 negative. This new study treatment has 3 parts: 1. A study drug called zolbetuximab 2. Another study drug called pembrolizumab 3. Standard chemotherapy (mFOLFOX or CAPOX) Researchers want to know if this combination is safe and if it works better than current treatments for people living with this specific type of stomach cancer

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Colorectal)
Open

Zilovertamab Vedotin+R-CHP vs Polatuzumab Vedotin+R-CHP for 1L DLBCL, GCB

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

Studying Updates in neuroCognition after Knee manipulation

Do you feel that your reaction time has slowed after your ACL injury? Has your ability to make decisions on the field/gym/court been impacted? If so, you may be eligible for a study examining the effect a quick joint manipulation has on your reaction time and decision making abilities after your ACL injury.

Age & Gender
  • 18 years ~ 35 years
  • Male, Female, Gender Inclusive
Study Interest
  • Alternative or Complementary Medicine
  • Bones, Joints, Muscles
  • Brain, Head, Nervous System
  • Injury/Injury Prevention
Visit Location
Coming Soon

Phase 1/2 Study of Etentamig in Combination with a CELMoD Agent for Relapsed/Refractory MM

The purpose of this study is to see at what doses of etentamig combined with Iberdomide is better tolerated and safe for patients with relapsed/refractory multiple myeloma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

Kidney Health Study

Do you or your child have a kidney condition and take certain meds? Join our study and help us make a difference! You'll also get paid for your time.

Age & Gender
  • 12 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Coming Soon

Get Real and Heel for patients with metastatic breast cancer

We want to see if people with breast cancer that has spread to other parts of the body can join and benefit from a 16-week exercise program at Get Real and Heel.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
  • Movement
Open

Teen Stress and Loss of Enjoyment Study

Do you have a teen between 13 and 15? You and your teen can join a study about how teens feel. Your teen can earn up to $590, and you can earn up to $225 for taking part.

Age & Gender
  • 13 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Child and Teen Health
  • Healthy Volunteer or General Population
  • and 6 more
Open

Evaluating Combinations of Medications After Stem Cell Transplant to Prevent Graft versus Host Disease and Infections

Do you have leukemia, lymphoma, MDS, or MF and are preparing for a stem cell transplant from an unrelated donor? If so, you might be eligible to take part in a study that will look look at combinations of medicines given after a stem cell transplant and see how well the combinations work to prevent graft versus host disease and infection.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers, Leukemia, Lymphoma)
  • Transplant
Open

Theatre Program Intervention for People with Parkinson's disease assessing vocal function, mood, and quality of life

No experience necessary! Be part of our theater group which utilizes movement, acting, improv, speech therapy and other approaches to improve quality of life for those living with Parkinson's disease and their carepartners! Participate in 8 sessions to enhance your theatrical skills and knowledge. You will then participate in a live performance. Experience the magic of live theater and be a part of this vibrant community event. You may be able to participate in a research study that assesses improvement in voice function, mood, and quality of life for people with Parkinson's Disease. Participating in the study is not required to participate in the program.

Age & Gender
  • 35 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Brain, Head, Nervous System
Visit Location
Coming Soon

Itraconazole for Preventiion in Barrett's Esophagus

We are looking for volunteers to join our study. We want to see if a medicine called itraconazole can help stop a condition called Barrett's Esophagus (BE) from coming back after treatment. This study will help us learn if itraconazole is safe and how it works compared to a pretend pill with no medicine, called a placebo. If you join, you will get either itraconazole or the placebo. Your participation will help us understand more about keeping BE from returning.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Stomach, Digestion and Gut Health
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research